These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8750011)

  • 1. Retroviral end-point titer is not predictive of gene transfer efficiency: implications for vector production.
    Forestell SP; Böhnlein E; Rigg RJ
    Gene Ther; 1995 Dec; 2(10):723-30. PubMed ID: 8750011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrovirus mediated in vivo gene transfer to synovium in bacterial cell wall-induced arthritis in rats.
    Makarov SS; Olsen JC; Johnston WN; Schwab JH; Anderle SK; Brown RR; Haskill JS
    Gene Ther; 1995 Aug; 2(6):424-8. PubMed ID: 7584118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of retrovirus production and decay.
    Le Doux JM; Davis HE; Morgan JR; Yarmush ML
    Biotechnol Bioeng; 1999 Jun; 63(6):654-62. PubMed ID: 10397822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the relative level of gene expression from different retroviral vectors used for gene therapy.
    Byun J; Kim SH; Kim JM; Yu SS; Robbins PD; Yim J; Kim S
    Gene Ther; 1996 Sep; 3(9):780-8. PubMed ID: 8875226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimized conditions for the production of recombinant amphotropic retroviral vector preparations.
    Kaptein LC; Greijer AE; Valerio D; van Beusechem VW
    Gene Ther; 1997 Feb; 4(2):172-6. PubMed ID: 9081708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased gene transfer into human CD34+ progenitor cells using retroviral vectors produced by a canine packaging cell line.
    Bauer G; Sauter S; Ibanez C; Rice CR; Valdez P; Jolly D; Kohn DB
    Biol Blood Marrow Transplant; 1998; 4(3):119-27. PubMed ID: 9923409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of retroviral vector generation for clinical application.
    Schilz AJ; Kühlcke K; Fauser AA; Eckert HG
    J Gene Med; 2001; 3(5):427-36. PubMed ID: 11601756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of culture parameters on the production of retroviral vectors by a human packaging cell line.
    McTaggart S; Al-Rubeai M
    Biotechnol Prog; 2000; 16(5):859-65. PubMed ID: 11027182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient and stable gene transfer of growth factors into chondrogenic cells and primary articular chondrocytes using a VSV.G pseudotyped retroviral vector.
    Vogt S; Ueblacker P; Geis C; Wagner B; Wexel G; Tischer T; Krüger A; Plank C; Anton M; Martinek V; Imhoff AB; Gansbacher B
    Biomaterials; 2008 Mar; 29(9):1242-9. PubMed ID: 18078987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High efficiencies of gene transfer with immobilized recombinant retrovirus: kinetics and optimization.
    Bajaj B; Lei P; Andreadis ST
    Biotechnol Prog; 2001; 17(4):587-96. PubMed ID: 11485416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant retroviral vector interferes with the detection of amphotropic replication competent retrovirus in standard culture assays.
    Printz M; Reynolds J; Mento SJ; Jolly D; Kowal K; Sajjadi N
    Gene Ther; 1995 Mar; 2(2):143-50. PubMed ID: 7719931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocyte growth factor expressed by a retrovirus-producing cell line enhances retroviral transduction of primary hepatocytes: implications for in vivo gene transfer.
    Pagès JC; Loux N; Bellusci S; Farge D; Bennoun M; Vons C; Jouanneau J; Franco D; Briand P; Weber A
    Biochem Biophys Res Commun; 1996 May; 222(3):726-31. PubMed ID: 8651912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retroviral vector production using suspension-adapted 293GPG cells in a 3L acoustic filter-based perfusion bioreactor.
    Ghani K; Garnier A; Coelho H; Transfiguracion J; Trudel P; Kamen A
    Biotechnol Bioeng; 2006 Nov; 95(4):653-60. PubMed ID: 16947907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of new retroviral producer cells from adenoviral and retroviral vectors.
    Lin X
    Gene Ther; 1998 Sep; 5(9):1251-8. PubMed ID: 9930327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative evaluation of gene transfer into blood cells using the same retroviral backbone for independent expression of the EGFP and deltaLNGFR marker genes.
    Giaretta I; Madeo D; Bonaguro R; Cappellari A; Rodeghiero F; Giorgio P
    Haematologica; 2000 Jul; 85(7):680-9. PubMed ID: 10897118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient transduction and seeding of human endothelial cells onto metallic stents using bicistronic pseudo-typed retroviral vectors encoding vascular endothelial growth factor.
    Koren B; Weisz A; Fischer L; Gluzman Z; Preis M; Avramovitch N; Cohen T; Cosset FL; Lewis BS; Flugelman MY
    Cardiovasc Revasc Med; 2006; 7(3):173-8. PubMed ID: 16945825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Construction and identification of recombinant retroviral vector containing human interleukin 1 receptor antagonist and its expression in osteoarthritic human articular chondrocytes].
    Rui Y; Wang Y; Zhang X; Sun H; Qu Z; Dai K
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 May; 22(5):533-8. PubMed ID: 18630429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An improved method for generating retroviral producer clones for vectors lacking a selectable marker gene.
    Persons DA; Mehaffey MG; Kaleko M; Nienhuis AW; Vanin EF
    Blood Cells Mol Dis; 1998 Jun; 24(2):167-82. PubMed ID: 9642098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy for malignant glioma using Sindbis vectors expressing a fusogenic membrane glycoprotein.
    Zhang J; Frolov I; Russell SJ
    J Gene Med; 2004 Oct; 6(10):1082-91. PubMed ID: 15368589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.